PATENT CLAIM ANALYSIS

Application Number: 16224747
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["435", "188000"]

Abstract:
The present disclosure provides engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof. Nucleic acid sequences encoding the engineered cross-type-nucleic-acid targeting nucleic acids, as well as expression cassettes, vectors and cells comprising such nucleic acid sequences, are described. Also, methods are disclosed for making and using the engineered cross-type-nucleic-acid targeting nucleic acids and compositions thereof.

Claim (Index 35):
A nucleic acid/protein composition, comprising:\n the engineered CRISPR Class 2 cross-type-NATNA of  claim 22 ; a catalytically active or catalytically inactive CRISPR Type II Cas9 protein; and a catalytically active or catalytically inactive CRISPR Type V Cpf1 protein.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 98.0
- Lexical Diversity: 1.74286
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16036599', '16166097', '15331676', '15787705', '15675677']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7575067689443171
- 35 USC 102 Novelty (BERT): 0.7101435146331115
- Combined Prediction Score: 0.7527704435131966
- Mean Citation Score: 792.630082
- Max Citation Score: 797.53845
- Similarity Product: 747.4922611958027

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test